NCT05808933 Magnetic Resonance Fingerprinting for Preoperative Evaluation of Lymphovascular Space Invasion in Early Stage Cervical Cancer
| NCT ID | NCT05808933 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Fondazione Policlinico Universitario Agostino Gemelli IRCCS |
| Condition | Cervical Cancer |
| Study Type | OBSERVATIONAL |
| Enrollment | 150 participants |
| Start Date | 2022-06-20 |
| Primary Completion | 2027-12 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 150 participants in total. It began in 2022-06-20 with a primary completion date of 2027-12.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The aim of this observational prospective study is to investigate the role of Magnetic Resonance Fingerprinting in preoperative assessment of early cervical cancer
Eligibility Criteria
Inclusion Criteria: * Patients with biopsy-proven cervical cancer FIGO stage IA-IIA undergoing surgery; * Women aged \>18 years old; * Signed Informed Consent. Exclusion Criteria: * Concurrent malignancies at other sites; * Previous history of neoplasm; * Refusal to sign written informed consent
Contact & Investigator
Frequently Asked Questions
Who can join the NCT05808933 clinical trial?
This trial is open to female participants only, aged 18 Years or older, studying Cervical Cancer. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05808933 currently recruiting?
Yes, NCT05808933 is actively recruiting participants. Contact the research team at benedetta.gui@policlinicogemelli.it for enrollment information.
Where is the NCT05808933 trial being conducted?
This trial is being conducted at Roma, Italy.
Who is sponsoring the NCT05808933 clinical trial?
NCT05808933 is sponsored by Fondazione Policlinico Universitario Agostino Gemelli IRCCS. The trial plans to enroll 150 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.